Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Alexander Azoy

Chief Accounting Officer at Arcus Biosciences, Inc. (RCUS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $396K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 24SEC RCUSArcus Biosciences, Inc. Sell Plan 2,82739,581 held (−7%) $30.00 $85K -18.6%
Jun 1SEC RCUSArcus Biosciences, Inc. Sell Plan 2,56239,581 held (−6%) $25.77 $66K -5.3%
Dec 18SEC RCUSArcus Biosciences, Inc. Sell Plan 2,37624,987 held (−9%) $21.88 $52K +11.6%
Dec 18SEC RCUSArcus Biosciences, Inc. Sell Plan 2,11322,874 held (−8%) $22.16 $47K +10.2%
Dec 18SEC RCUSArcus Biosciences, Inc. Sell Plan 4,34318,531 held (−19%) $22.25 $97K +9.7%
Dec 1SEC RCUSArcus Biosciences, Inc. Sell Plan 1,90027,363 held (−6%) $26.00 $49K -6.1%
  • Sell

    Chief Accounting Officer Alexander Azoy sold $85K of RCUS at $30.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Alexander Azoy sold $66K of RCUS at $25.77 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Alexander Azoy sold $52K of RCUS at $21.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Alexander Azoy sold $47K of RCUS at $22.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Alexander Azoy sold $97K of RCUS at $22.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Accounting Officer Alexander Azoy sold $49K of RCUS at $26.00 — pre-scheduled 10b5-1 plan sale.